Eftychia Chatziioannou

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Venues

American journal of clinical dermatology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, Ulrike Keim, Olivia Seeber, Andreas Meiwes, Isabell Boessenecker, Stephanie Sanchez Gonzalez, Francisco Merraz Torres, Heike Niessner, Tobias Sinnberg, Andrea Forschner, Lukas Flatz, Teresa Amaral
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy. American journal of clinical dermatology 24 (3) (2023)
Lisa Marie Fröhlich, Heike Niessner, Birgit Sauer, Sofie Kämereit, Eftychia Chatziioannou, Simon Riel, Tobias Sinnberg, Birgit Schittek
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo . Cancer research communications 3 (9) (2023)
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, Ulrike Keim, Olivia Seeber, Andreas Meiwes, Isabell Boessenecker, Stephanie Sanchez Gonzalez, Francisco Merraz Torres, Heike Niessner, Tobias Sinnberg, Andrea Forschner, Lukas Flatz, Teresa Amaral
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy. American journal of clinical dermatology 24 (3) (2023)
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, Ulrike Keim, Olivia Seeber, Andreas Meiwes, Isabell Boessenecker, Stephanie Sanchez Gonzalez, Francisco Merraz Torres, Heike Niessner, Tobias Sinnberg, Andrea Forschner, Lukas Flatz, Teresa Amaral
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy. American journal of clinical dermatology 24 (3) (2023)
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, Ulrike Keim, Olivia Seeber, Andreas Meiwes, Isabell Boessenecker, Stephanie Sanchez Gonzalez, Francisco Merraz Torres, Heike Niessner, Tobias Sinnberg, Andrea Forschner, Lukas Flatz, Teresa Amaral
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy. American journal of clinical dermatology (2023)
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, Ulrike Keim, Olivia Seeber, Andreas Meiwes, Isabell Boessenecker, Stephanie Sanchez Gonzalez, Francisco Merraz Torres, Heike Niessner, Tobias Sinnberg, Andrea Forschner, Lukas Flatz, Teresa Amaral
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy. American journal of clinical dermatology 24 (3) (2023)
Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, Ulrike Keim, Olivia Seeber, Andreas Meiwes, Isabell Boessenecker, Stephanie Sanchez Gonzalez, Francisco Merraz Torres, Heike Niessner, Tobias Sinnberg, Andrea Forschner, Lukas Flatz, Teresa Amaral
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy. American journal of clinical dermatology 24 (3) (2023)

Eftychia Chatziioannou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eftychia Chatziioannou